Safe Orthopaedics SA
Safe Orthopaedics SA, a medical technology company, develops and markets ready-to-use implants and sterile instrumentation for spinal surgery in France. It offers SteriSpine PS, an all-round kit for open, mini open, and MIS surgeries, as well as percutaneous kit; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation for lu… Read more
Safe Orthopaedics SA (ALSAF) - Net Assets
Latest net assets as of June 2025: €-15.70 Million EUR
Based on the latest financial reports, Safe Orthopaedics SA (ALSAF) has net assets worth €-15.70 Million EUR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€7.94 Million) and total liabilities (€23.64 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €-15.70 Million |
| % of Total Assets | -197.76% |
| Annual Growth Rate | N/A |
| 5-Year Change | -3653.59% |
| 10-Year Change | -265.4% |
| Growth Volatility | 223.11 |
Safe Orthopaedics SA - Net Assets Trend (2012–2024)
This chart illustrates how Safe Orthopaedics SA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Safe Orthopaedics SA (2012–2024)
The table below shows the annual net assets of Safe Orthopaedics SA from 2012 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €-8.42 Million | +95.84% |
| 2023-12-31 | €-202.35 Million | -15721.27% |
| 2022-12-31 | €-1.28 Million | -421.36% |
| 2021-12-31 | €398.00K | +67.93% |
| 2020-12-31 | €237.00K | +105.54% |
| 2019-12-31 | €-4.28 Million | -458.84% |
| 2018-12-31 | €1.19 Million | +12.76% |
| 2017-12-31 | €1.06 Million | +188.28% |
| 2016-12-31 | €367.00K | -92.79% |
| 2015-12-31 | €5.09 Million | +106.82% |
| 2014-12-31 | €2.46 Million | +1369.07% |
| 2013-12-31 | €-194.00K | -116.61% |
| 2012-12-31 | €1.17 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Safe Orthopaedics SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4615200000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €37.00K | % |
| Other Components | €41.04 Million | % |
| Total Equity | €-8.42 Million | 100.00% |
Safe Orthopaedics SA Competitors by Market Cap
The table below lists competitors of Safe Orthopaedics SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
PANASONIC (MAT1.SG)
STU:MAT1
|
$139.55K |
|
Maj Invest Grønne Obligationer
CO:MAJGRO
|
$139.68K |
|
Sociedad Minera Cerro Verde S.A.A.
LIM:CVERDEC1
|
$139.72K |
|
LEIFHEIT AG - Dusseldorf Stock Exchang
DU:LEI
|
$139.76K |
|
Eurospan Holdings Bhd
KLSE:7094
|
$139.42K |
|
KUBOTA CORP - Dusseldorf Stock Exchang
DU:KUO1
|
$139.33K |
|
Soluciones Cuatroochenta S.L.
MC:480S
|
$139.30K |
|
GIGLIO GROUP S.P.A. O.N.
F:5JR
|
$139.29K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Safe Orthopaedics SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -202,355,000 to -8,422,000, a change of 193,933,000.
- Net loss of 1,929,324,000 reduced equity.
- Share repurchases of 2,123,505,000 reduced equity.
- New share issuances of 2,123,505,000 increased equity.
- Other factors increased equity by 2,123,257,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-1.93 Billion | -22908.15% |
| Share Repurchases | €2.12 Billion | -25213.79% |
| Share Issuances | €2.12 Billion | +25213.79% |
| Other Changes | €2.12 Billion | +25210.84% |
| Total Change | €- | % |
Book Value vs Market Value Analysis
This analysis compares Safe Orthopaedics SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | €0.00 | €0.92 | x |
| 2013-12-31 | €0.00 | €0.92 | x |
| 2014-12-31 | €0.00 | €0.92 | x |
| 2015-12-31 | €0.00 | €0.92 | x |
| 2016-12-31 | €0.00 | €0.92 | x |
| 2017-12-31 | €0.00 | €0.92 | x |
| 2018-12-31 | €0.00 | €0.92 | x |
| 2019-12-31 | €0.00 | €0.92 | x |
| 2020-12-31 | €5925000.00 | €0.92 | x |
| 2021-12-31 | €3255.62 | €0.92 | x |
| 2022-12-31 | €-10462.17 | €0.92 | x |
| 2023-12-31 | €-2312892.90 | €0.92 | x |
| 2024-12-31 | €-1090.93 | €0.92 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Safe Orthopaedics SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -38272.64%
- • Asset Turnover: 0.46x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-657.75%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -286.90% | -1027.91% | 0.09x | 3.00x | €-3.47 Million |
| 2013 | 0.00% | -330.20% | 0.23x | 0.00x | €-3.17 Million |
| 2014 | -200.49% | -240428.64% | 0.00x | 2.16x | €-5.18 Million |
| 2015 | -128.95% | -262850.28% | 0.00x | 2.05x | €-7.08 Million |
| 2016 | -1636.24% | -253911.21% | 0.00x | 21.81x | €-6.04 Million |
| 2017 | -622.04% | -211414.79% | 0.00x | 7.62x | €-6.68 Million |
| 2018 | -485.76% | -167098.82% | 0.00x | 7.18x | €-5.92 Million |
| 2019 | 0.00% | -169.61% | 0.83x | 0.00x | €-7.54 Million |
| 2020 | -3504.64% | -227.06% | 0.25x | 60.54x | €-8.33 Million |
| 2021 | -1685.68% | -147.32% | 0.31x | 37.39x | €-6.75 Million |
| 2022 | 0.00% | -118.84% | 0.35x | 0.00x | €-6.84 Million |
| 2023 | 0.00% | -3536.04% | 0.07x | 0.00x | €-185.21 Million |
| 2024 | 0.00% | -38272.64% | 0.46x | 0.00x | €-1.93 Billion |
Industry Comparison
This section compares Safe Orthopaedics SA's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $692,749,273
- Average return on equity (ROE) among peers: -134.17%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Safe Orthopaedics SA (ALSAF) | €-15.70 Million | -286.90% | N/A | $139.52K |
| Crossject (ALCJ) | $1.65 Million | -647.41% | 11.18x | $105.49 Million |
| I.Ceram SA (ALICR) | $2.61 Million | -58.47% | 1.19x | $95.27K |
| Spineway (ALSPW) | $22.01 Million | -14.25% | 0.26x | $6.68 Million |
| Amplitude Surgical SAS (AMPLI) | $85.50 Million | -10.51% | 2.27x | $14.07 Million |
| EssilorLuxottica S. A. (EL) | $4.04 Billion | 14.67% | 0.88x | $61.18 Billion |
| Bonyf NV (MLBON) | $3.73 Million | -89.06% | 0.12x | $43.34K |